TNF-α is one of the central cytokines involved in inflammation initiation and amplification in virus infections (42), and is reported to be elevated in critical COVID-19 cases (3, 43), suggesting it as a proper indicator for in vitro drug screening. The gene discussed is TNF; the disease is COVID-19.